ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/11/09 | 1,444 | 1,450 | 1,381 | 1,387 | -62 | -4.3% | 194,900 |
2017/11/08 | 1,467 | 1,467 | 1,448 | 1,449 | -3 | -0.2% | 58,600 |
2017/11/07 | 1,453 | 1,460 | 1,442 | 1,452 | +3 | +0.2% | 56,800 |
2017/11/06 | 1,466 | 1,473 | 1,449 | 1,449 | -9 | -0.6% | 47,900 |
2017/11/02 | 1,489 | 1,489 | 1,456 | 1,458 | -2 | -0.1% | 69,200 |
2017/11/01 | 1,470 | 1,490 | 1,448 | 1,460 | -14 | -0.9% | 113,300 |
2017/10/31 | 1,503 | 1,503 | 1,473 | 1,474 | -26 | -1.7% | 53,400 |
2017/10/30 | 1,481 | 1,509 | 1,480 | 1,500 | +20 | +1.4% | 83,400 |
2017/10/27 | 1,471 | 1,488 | 1,470 | 1,480 | +6 | +0.4% | 53,600 |
2017/10/26 | 1,487 | 1,487 | 1,460 | 1,474 | +8 | +0.5% | 47,500 |
2017/10/25 | 1,488 | 1,488 | 1,455 | 1,466 | -4 | -0.3% | 42,000 |
2017/10/24 | 1,475 | 1,480 | 1,461 | 1,470 | -4 | -0.3% | 43,600 |
2017/10/23 | 1,494 | 1,494 | 1,473 | 1,474 | -17 | -1.1% | 57,400 |
2017/10/20 | 1,491 | 1,491 | 1,466 | 1,491 | +26 | +1.8% | 68,300 |
2017/10/19 | 1,495 | 1,499 | 1,465 | 1,465 | -43 | -2.9% | 158,600 |
2017/10/18 | 1,520 | 1,521 | 1,462 | 1,508 | -13 | -0.9% | 151,000 |
2017/10/17 | 1,517 | 1,525 | 1,505 | 1,521 | +16 | +1.1% | 178,700 |
2017/10/16 | 1,502 | 1,517 | 1,501 | 1,505 | -8 | -0.5% | 83,500 |
2017/10/13 | 1,490 | 1,513 | 1,477 | 1,513 | +38 | +2.6% | 144,500 |
2017/10/12 | 1,491 | 1,531 | 1,460 | 1,475 | +2 | +0.1% | 164,400 |
2017/10/11 | 1,470 | 1,510 | 1,453 | 1,473 | +26 | +1.8% | 75,200 |
2017/10/10 | 1,485 | 1,489 | 1,447 | 1,447 | -33 | -2.2% | 45,900 |
2017/10/06 | 1,440 | 1,500 | 1,440 | 1,480 | +41 | +2.8% | 75,300 |
2017/10/05 | 1,470 | 1,470 | 1,438 | 1,439 | -29 | -2% | 64,700 |
2017/10/04 | 1,510 | 1,518 | 1,462 | 1,468 | -42 | -2.8% | 89,900 |
2017/10/03 | 1,488 | 1,510 | 1,478 | 1,510 | -2 | -0.1% | 134,100 |
2017/10/02 | 1,418 | 1,512 | 1,414 | 1,512 | +98 | +6.9% | 274,900 |
2017/09/29 | 1,385 | 1,419 | 1,375 | 1,414 | +25 | +1.8% | 126,900 |
2017/09/28 | 1,373 | 1,390 | 1,370 | 1,389 | +7 | +0.5% | 65,600 |
2017/09/27 | 1,383 | 1,398 | 1,371 | 1,382 | -5 | -0.4% | 53,000 |
2017/09/26 | 1,374 | 1,409 | 1,374 | 1,387 | -2 | -0.1% | 38,500 |
2017/09/25 | 1,373 | 1,399 | 1,370 | 1,389 | +23 | +1.7% | 35,700 |
2017/09/22 | 1,400 | 1,400 | 1,366 | 1,366 | -30 | -2.1% | 71,900 |
2017/09/21 | 1,408 | 1,408 | 1,388 | 1,396 | ±0 | ±0% | 58,300 |
2017/09/20 | 1,381 | 1,403 | 1,381 | 1,396 | -3 | -0.2% | 30,200 |
2017/09/19 | 1,365 | 1,400 | 1,365 | 1,399 | +31 | +2.3% | 67,900 |
2017/09/15 | 1,361 | 1,378 | 1,360 | 1,368 | -2 | -0.1% | 39,600 |
2017/09/14 | 1,389 | 1,396 | 1,367 | 1,370 | -19 | -1.4% | 48,800 |
2017/09/13 | 1,419 | 1,419 | 1,388 | 1,389 | -26 | -1.8% | 46,900 |
2017/09/12 | 1,390 | 1,415 | 1,385 | 1,415 | +37 | +2.7% | 57,500 |
2017/09/11 | 1,381 | 1,404 | 1,364 | 1,378 | +27 | +2% | 38,000 |
2017/09/08 | 1,399 | 1,400 | 1,345 | 1,351 | -31 | -2.2% | 98,600 |
2017/09/07 | 1,438 | 1,438 | 1,375 | 1,382 | -28 | -2% | 51,000 |
2017/09/06 | 1,360 | 1,422 | 1,359 | 1,410 | +32 | +2.3% | 82,700 |
2017/09/05 | 1,418 | 1,440 | 1,362 | 1,378 | -48 | -3.4% | 150,800 |
2017/09/04 | 1,466 | 1,468 | 1,409 | 1,426 | -63 | -4.2% | 174,100 |
2017/09/01 | 1,490 | 1,495 | 1,484 | 1,489 | +4 | +0.3% | 76,600 |
2017/08/31 | 1,480 | 1,499 | 1,476 | 1,485 | +15 | +1% | 120,900 |
2017/08/30 | 1,487 | 1,487 | 1,455 | 1,470 | +7 | +0.5% | 49,800 |
2017/08/29 | 1,450 | 1,463 | 1,448 | 1,463 | +8 | +0.5% | 37,300 |
1901~
1950
件表示中 / 2491件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
クオリプス | 739,000円 | +237.1% | - | 0.00% | - | 11.01倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 58,300円 | +11.5% | -0.9% | 4.80% | 6.98倍 | 3.45倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム